.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Express Scripts
McKinsey
Colorcon
Dow
Moodys
Cerilliant
Daiichi Sankyo
Chinese Patent Office
Julphar

Generated: November 24, 2017

DrugPatentWatch Database Preview

Propafenone hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for propafenone hydrochloride and what is the scope of propafenone hydrochloride patent protection?

Propafenone hydrochloride
is the generic ingredient in three branded drugs marketed by Mylan Pharms Inc, Watson Labs, Glaxosmithkline Llc, Vintage Pharms, Par Pharm, Orion Corp Orion, Ani Pharms Inc, Glenmark Pharms Ltd, Watson Labs Inc, Nesher Pharms, and Sun Pharm Inds, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for propafenone hydrochloride. Twenty suppliers are listed for this compound.

Pharmacology for propafenone hydrochloride

Drug ClassAntiarrhythmic

Medical Subject Heading (MeSH) Categories for propafenone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205268-001Sep 8, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Inc
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL202688-002Aug 24, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
TABLET;ORAL075998-003Nov 29, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline Llc
RYTHMOL SR
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021416-002Sep 4, 2003ABRXYesNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
TABLET;ORAL076193-002Feb 7, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Vintage Pharms
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
TABLET;ORAL075938-002Oct 17, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Vintage Pharms
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
TABLET;ORAL075938-003Oct 17, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Nesher Pharms
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
TABLET;ORAL076193-003Feb 7, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL078540-002Oct 18, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL203803-003Apr 29, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: propafenone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc
RYTHMOL SR
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021416-001Sep 4, 2003► Subscribe► Subscribe
Glaxosmithkline Llc
RYTHMOL SR
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021416-003Sep 4, 2003► Subscribe► Subscribe
Glaxosmithkline Llc
RYTHMOL SR
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL021416-002Sep 4, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Deloitte
Merck
Moodys
UBS
Chubb
AstraZeneca
Express Scripts
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot